Nissay Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.8M | Buy |
164,864
+2,433
| +1% | +$187K | 0.06% | 196 |
|
|
2025
Q4 | $12.9M | Buy |
162,431
+1,889
| +1% | +$149K | 0.07% | 188 |
|
|
2025
Q3 | $12.1M | Buy |
160,542
+1,775
| +1% | +$122K | 0.07% | 190 |
|
|
2025
Q2 | $11M | Buy |
158,767
+241
| +0.2% | +$15.8K | 0.06% | 207 |
|
|
2025
Q1 | $10.7M | Buy |
158,526
+1,956
| +1% | +$117K | 0.07% | 194 |
|
|
2024
Q4 | $6.97M | Sell |
156,570
-1,049
| -0.7% | -$58.8K | 0.04% | 266 |
|
|
2024
Q3 | $9.91M | Buy |
157,619
+3,931
| +3% | +$229K | 0.06% | 205 |
|
|
2024
Q2 | $9.08M | Buy |
153,688
+1,441
| +0.9% | +$90.1K | 0.06% | 198 |
|
|
2024
Q1 | $12.1M | Sell |
152,247
-1,071
| -0.7% | -$81.8K | 0.08% | 158 |
|
|
2023
Q4 | $12.1M | Buy |
153,318
+6,132
| +4% | +$436K | 0.1% | 139 |
|
|
2023
Q3 | $10.3M | Buy |
147,186
+4,926
| +3% | +$349K | 0.09% | 138 |
|
|
2023
Q2 | $9.83M | Sell |
142,260
-6,659
| -4% | -$474K | 0.08% | 141 |
|
|
2023
Q1 | $11.1M | Sell |
148,919
-214,268
| -59% | -$18M | 0.1% | 132 |
|
|
2022
Q4 | $33.8M | Sell |
363,187
-326,492
| -47% | -$31.5M | 0.32% | 61 |
|
|
2022
Q3 | $65.8M | Buy |
689,679
+324,055
| +89% | +$32.1M | 0.69% | 24 |
|
|
2022
Q2 | $33.9M | Sell |
365,624
-505,820
| -58% | -$49.4M | 0.34% | 49 |
|
|
2022
Q1 | $88.2M | Buy |
871,444
+671,789
| +336% | +$70.6M | 0.77% | 21 |
|
|
2021
Q4 | $20.6M | Buy |
199,655
+18,376
| +10% | +$1.7M | 0.16% | 89 |
|
|
2021
Q3 | $15.4M | Buy |
181,279
+3,841
| +2% | +$322K | 0.13% | 102 |
|
|
2021
Q2 | $14.8M | Sell |
177,438
-53,259
| -23% | -$4.36M | 0.13% | 109 |
|
|
2021
Q1 | $17.4M | Buy |
230,697
+23,379
| +11% | +$1.7M | 0.17% | 84 |
|
|
2020
Q4 | $14.2M | Buy |
207,318
+825
| +0.4% | +$53.7K | 0.21% | 98 |
|
|
2020
Q3 | $12.1M | Sell |
206,493
-27,595
| -12% | -$1.72M | 0.2% | 104 |
|
|
2020
Q2 | $15.2M | Buy |
234,088
+20,280
| +9% | +$1.28M | 0.3% | 88 |
|
|
2020
Q1 | $12.7M | Buy |
213,808
+2,325
| +1% | +$155K | 0.32% | 83 |
|
|
2019
Q4 | $15.7M | Sell |
211,483
-7,592
| -3% | -$533K | 0.35% | 72 |
|
|
2019
Q3 | $13.8M | Buy |
219,075
+67,945
| +45% | +$4.03M | 0.34% | 75 |
|
|
2019
Q2 | $8.23M | Sell |
151,130
-1,344
| -0.9% | -$72.4K | 0.21% | 116 |
|
|
2019
Q1 | $8.22M | Sell |
152,474
-3,236
| -2% | -$200K | 0.22% | 118 |
|
|
2018
Q4 | $10.2M | Buy |
155,710
+26,334
| +20% | +$1.97M | 0.31% | 79 |
|
|
2018
Q3 | $10.2M | Buy |
129,376
+6,116
| +5% | +$437K | 0.27% | 85 |
|
|
2018
Q2 | $7.93M | Buy |
123,260
+753
| +0.6% | +$49.6K | 0.23% | 106 |
|
|
2018
Q1 | $7.62M | Sell |
122,507
-3,778
| -3% | -$271K | 0.24% | 99 |
|
|
2017
Q4 | $9.16M | Buy |
+126,285
| New | +$9.18M | 0.28% | 87 |
|
Other funds holding CVS
VCM
VPM
Nissay Asset Management's CVS Position: Q1 2026 in Review
Nissay Asset Management increased its CVS Health (CVS) stake by 1.5% in Q1 2026, buying an estimated $187K and bringing the position to 164,864 shares worth $11.8M. The position accounts for 0.06% of the portfolio, ranked #196.
Nissay Asset Management first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $88.2M in Q1 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Nissay Asset Management held 164,864 shares of CVS Health worth $11.8M as of Q1 2026.
- Nissay Asset Management bought 2,433 CVS Health shares in Q1 2026, an estimated $187K.
- CVS Health made up 0.06% of Nissay Asset Management's portfolio in Q1 2026, its #196 holding.
- Nissay Asset Management first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's CVS Health position peaked at $88.2M in Q1 2022.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.